SecBot SecBot

ETHIC Act

H.R. 3269 Rep. Jodey Arrington (R-TX-19) In committee
Bill text PDF
  1. Introduced May 8
  2. Committee May 8
  3. Passed House Next
  4. Passed Senate Not yet
  5. To President Not yet
  6. Law Not yet
Where it stands
In committee, May 8, 2025Next: House vote
538d ago May 8, 2025: Referred to the House Committee on the Judiciary.
Final votes
No roll callsNo recorded vote on this bill yet
Lobbying
4companies, 21 filings
Subscribe to see spend
Member trades
11trades in the last 90 days
Subscribe to see who
Who backs the bill and who pushes back Subscribe

Companies lobbying on this bill

4 companies
Companies by sector
Biotech & Pharma 4
Search all 4 companies, their asks and price moves Subscribe

Summary

This bill, the ETHIC Act, aims to address patent thickets by limiting the number of patents that can be asserted in certain infringement actions. Sec. 2, Addressing patent thickets: This section amends patent law to limit a person bringing a patent infringement action against a drug or biological product applicant or maker to asserting no more than one patent per Patent Group. A Patent Group is defined as two or more commonly owned patents or applications that are linked through disclaimers under patent law. The person also cannot bring additional actions asserting a patent in the same Patent Group against that party. The amendment applies to applications submitted on or after the date the bill is enacted.

Summary of the bill text as introduced in House (May 8, 2025), generated by SecBot from the official bill text; the Library of Congress summary is not yet published.

Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 27, 2026.